H. Yorimitsu, K. Oshima, and T. Kobayashi
FULL PAPERS
128.66, 129.12, 129.59, 129.83, 130.87, 136.44, 137.86, 148.24, 162.06 ppm;
elemental analysis: calcd (%) for C19H17N: C 87.99, H 6.61; found:
C 88.07, H 6.83.
6.12 (dt, J=15.5, 7.0 Hz, 1H), 6.36 (d, J=15.5 Hz, 1H), 6.83 (d, J=
9.0 Hz, 2H), 7.11 (dd, J=5.0, 7.5 Hz, 1H), 7.16 (d, J=7.5 Hz, 1H), 7.26
(d, J=9.0 Hz, 2H), 7.58 (dd, J=7.5, 7.5 Hz, 1H), 8.55 ppm (d, J=5.0 Hz,
1H); 13C NMR (CDCl3): d=33.25, 38.50, 55.45, 114.07, 121.24, 123.04,
127.25, 127.68, 130.07, 130.69, 136.42, 149.51, 158.92, 161.61 ppm; HRMS
(DI-EI+) (m/z) observed:239.1315 (D=+2.2 ppm); calcd for C16H17NO
[M+]: 239.1310.
1-Phenyl-4-(2-thiazolyl)-1-butene (3e): IR (neat): n˜ =3024, 2847, 1705,
1497, 964, 741 cmÀ1 1H NMR (CDCl3): d=2.73 (dt, J=7.0, 7.0 Hz, 2H),
;
3.21 (t, J=7.0 Hz, 2H), 6.26 (dt, J=16.0, 7.0 Hz, 1H), 6.46 (d, J=
16.0 Hz, 1H), 7.19 (d, J=3.0 Hz, 1H), 7.20–7.22 (m, 1H), 7.27–7.35 (m,
4H), 7.70 ppm (d, J=3.0 Hz, 1H); 13C NMR (CDCl3): d=33.27, 33.29,
118.36, 126.26, 127.35, 128.53, 128.68, 131.59, 137.54, 142.47, 170.33 ppm;
elemental analysis: calcd (%) for C13H13NS: C 72.52, H 6.09; found:
C 72.73, H 6.13.
4-(2-Pyridyl)-1-(4-trifluoromethylphenyl)-1-butene (3q): m.p.: 66–698C.
IR (nujol): n˜ =2855, 2677, 2361, 1458, 1373, 1126 cmÀ1
;
1H NMR
(CDCl3): d=2.70 (dt, J=6.5, 7.5 Hz, 2H), 2.98 (t, J=7.5 Hz, 2H), 6.37
(dt, J=16.0, 6.5 Hz, 1H), 6.45 (d, J=16.0 Hz, 1H), 7.13 (dd, J=5.0,
7.5 Hz, 1H), 7.17 (d, J=7.5 Hz, 1H), 7.40 (d, J=8.0 Hz, 2H), 7.53 (d, J=
8.0 Hz, 2H), 7.60 (dd, J=7.5, 7.5 Hz, 1H), 8.56 ppm (d, J=5.0 Hz, 1H);
13C NMR (CDCl3): d=33.17, 38.02, 121.38, 123.03, 123.37, 125.58 (q, J=
31.0 Hz), 126.29, 128.95 (q, J=257 Hz), 129.57, 132.73, 136.51, 141.31,
149.58, 161.18 ppm; HRMS (DI-EI+) (m/z) observed: 277.1074 (D=
À1.7 ppm); calcd for C16H14F3N [M+]: 277.1078.
1-Phenyl-4-(3-methyl-2-pyridyl)-1-butene (3i): IR (neat): n˜ =3024, 2932,
1582, 1450, 965, 741 cmÀ1 1H NMR (CDCl3): d=2.33 (s, 3H), 2.65 (dt,
;
J=7.0. 8.0 Hz, 2H), 2.95 (t, J=8.0 Hz, 2H), 6.32 (dt, J=16.0, 7.0 Hz,
1H), 6.44 (d, J=16.0 Hz, 1H), 7.04 (dd, J=5.0, 7.5 Hz, 1H), 7.19 (dd, J=
7.0, 7.0 Hz, 1H), 7.26–7.35 (m, 4H), 7.41 (d, J=7.5 Hz, 1H), 8.40 ppm (d,
J=5.0 Hz, 1H); 13C NMR (CDCl3): d=19.02, 32.25, 35.39, 121.39, 126.18,
127.09, 128.65, 130.25, 130.51, 131.15, 137.73, 137.92, 146.95, 159.74 ppm;
elemental analysis: calcd (%) for C16H17N: C 86.05, H 7.67; found:
C 85.80, H 7.74.
1-(4-Chlorophenyl)-4-(2-pyridyl)-1-butene (3r): m.p.: 51–528C. IR
(nujol): n˜ =2924, 2855, 2700, 1458, 1373, 1304, 964 cmÀ1
;
1H NMR
(CDCl3): d=2.66 (dt, J=7.0, 8.0 Hz, 2H), 2.96 (t, J=8.0 Hz, 2H), 6.24
(dt, J=16.0, 7.0 Hz, 1H), 6.37 (d, J=16.0 Hz, 1H), 7.12 (dd, J=4.5,
8.0 Hz, 1H), 7.16 (d, J=8.0 Hz, 1H), 7.24 (s, 4H), 7.60 (dd, J=8.0,
8.0 Hz, 1H), 8.55 ppm (d, J=4.5 Hz, 1H); 13C NMR (CDCl3): d=33.18,
38.21, 121.35, 123.05, 127.39, 128.77, 129.59, 130.62, 132.69, 136.35, 136.49,
149.57, 161.35 ppm; elemental analysis: calcd (%) for C15H14ClN:
C 73.92, H 5.79; found: C 73.88, H 5.82.
1-Phenyl-4-(4-methyl-2-pyridyl)-1-butene (3j): IR (neat): n˜ =3024, 2924,
1605, 1443, 964, 741 cmÀ1 1H NMR (CDCl3): d=2.32 (s, 3H), 2.65 (dt,
;
J=6.5, 7.5 Hz, 2H), 2.92 (t, J=7.5 Hz, 2H), 6.27 (dt, J=16.0, 6.5 Hz,
1H), 6.43 (d, J=16.0 Hz, 1H), 6.94 (d, J=5.0 Hz, 1H), 7.00 (s, 1H),
7.17–7.21 (m, 1H), 7.25–7.34 (m, 4H), 8.40 ppm (d, J=5.0 Hz, 1H);
13C NMR (CDCl3): d=21.18, 33.31, 38.19, 122.34, 123.95, 126.18, 127.10,
128.64, 130.02, 130.63, 137.89, 147.53, 149.24, 161.23 ppm; HRMS (DI-
EI+) (m/z) observed: 223.1362 (D=+0.4 ppm); calcd for C16H17N [M+]:
223.1361.
4-(2-Pyridyl)-1-(2-thienyl)-1-butene (3 s): IR (neat): n˜ =3071, 2845, 1589,
1435, 957, 694 cmÀ1 1H NMR (CDCl3): d=2.62 (dt, J=7.0, 7.5 Hz, 2H),
;
2.94 (t, J=7.5 Hz, 2H), 6.11 (dt, J=15.5, 7.0 Hz, 1H), 6.54 (d, J=
15.5 Hz, 1H), 6.85 (d, J=3.5 Hz, 1H), 6.91 (dd, J=3.5, 5.0 Hz, 1H), 7.07
(d, J=5.0 Hz, 1H), 7.10 (dd, J=5.0, 7.5 Hz, 1H), 7.15 (d, J=7.5 Hz, 1H),
7.58 (dd, J=7.5, 7.5 Hz, 1H), 8.54 ppm (d, J=5.0 Hz, 1H); 13C NMR
(CDCl3): d=32.97, 38.15, 121.29, 123.02, 123.42, 123.96, 124.58, 127.36,
129.81, 136.43, 143.01, 149.52, 161.32 ppm; HRMS (DI-EI+) (m/z) ob-
served: 215.0768 (D=À0.6 ppm); calcd for C13H13NS [M+]: 215.0769.
1-Phenyl-4-(5-methyl-2-pyridyl)-1-butene (3k): IR (neat): n˜ =2924, 2855,
1
1458, 1373, 964 cmÀ1; H NMR (CDCl3): d=2.30 (s, 3H), 2.64 (dt, J=6.8,
7.8 Hz, 2H), 2.92 (t, J=7.8 Hz, 2H), 6.26 (dt, J=16.0, 6.8 Hz, 1H), 6.41
(d, J=16.0 Hz, 1H), 7.06 (d, J=8.0 Hz, 1H), 7.16–7.21 (m, 1H), 7.25–
7.34 (m, 4H), 7.40 (d, J=8.0 Hz, 1H), 8.37 ppm (s, 1H); 13C NMR
(CDCl3): d=18.23, 33.39, 37.84, 122.49, 126.17, 127.08, 128.63, 130.01,
130.48, 130.63, 137.08, 137.89, 149.85, 158.46 ppm; elemental analysis:
calcd (%) for C16H17N: C 86.05, H 7.67; found: C 86.06, H 7.78.
3-Methyl-1-phenyl-4-(2-pyridyl)-1-butene (3m): IR (neat): n˜ =3024, 2963,
1
1589, 1435, 964, 748 cmÀ1; H NMR (CDCl3): d=1.12 (d, J=6.0 Hz, 3H),
Acknowledgements
2.81 (dd, J=6.0, 12.0 Hz, 1H), 2.83–2.90 (m, 1H), 2.92 (dd, J=6.0,
12.0 Hz, 1H), 6.18 (dd, J=7.0, 16.0 Hz, 1H), 6.30 (d, J=16.0 Hz, 1H),
7.08–7.13 (m, 2H), 7.14–7.20 (m, 1H), 7.25–7.32 (m, 4H), 7.57 (dt, J=
2.0, 7.5 Hz, 1H), 8.53 ppm (d, J=4.5 Hz, 1H); 13C NMR (CDCl3): d=
20.23, 37.92, 45.97, 121.25, 123.90, 126.20, 127.06, 128.61, 128.66, 135.72,
136.24, 137.89, 149.46, 160.71 ppm; HRMS (DI-EI+) (m/z) observed:
223.1364 (D=+1.5 ppm); calcd for C16H17N [M+]: 223.1361.
This work was supported by Grants-in-Aid for Scientific Research and
GCOE Research from JSPS.
[1] a) M. P. Sibi, S. Manyem, Tetrahedron 2000, 56, 8033–8061; b) N.
1-(4-Methylphenyl)-4-(2-pyridyl)-1-butene (3n): IR (neat): n˜ =3017,
1
2924, 2855, 1589, 1435, 964, 733 cmÀ1; H NMR (CDCl3): d=2.31 (s, 3H),
2.65 (dt, J=7.0, 7.5 Hz, 2H), 2.96 (t, J=7.5 Hz, 2H), 6.21 (dt, J=15.5,
7.0 Hz, 1H), 6.39 (d, J=15.5 Hz, 1H), 7.09 (d, J=8.0 Hz, 2H), 7.11 (dd,
J=5.0, 8.0 Hz, 1H), 7.16 (d, J=8.0 Hz, 1H), 7.22 (d, J=8.0 Hz, 2H), 7.58
(dd, J=8.0, 8.0 Hz, 1H), 8.55 ppm (d, J=5.0 Hz, 1H); 13C NMR
(CDCl3): d=21.30, 33.24, 38.42, 121.25, 123.05, 126.08, 128.82, 129.33,
130.57, 135.08, 136.42, 136.83, 149.53, 161.59 ppm; elemental analysis:
calcd (%) for C16H17N: C 86.05, H 7.67; found: C 86.24, H 7.84.
[3] M. Lautens, A. Roy, K. Fukuoka, K. Fagnou, B. Martin-Matute, J.
1-(2-Methylphenyl)-4-(2-pyridyl)-1-butene (3o): IR (neat): n˜ =3402,
[4] For rhodium-catalyzed addition of arylboronic acids to alkynyl aza-
heteroaromatic compounds, see: a) M. Lautens, M. Yoshida, J. Org.
1
3017, 2361, 1589, 1435, 964, 748 cmÀ1; H NMR (CDCl3): d=3.26 (s, 3H),
2.68 (dt, J=7.0, 7.5 Hz, 2H), 2.98 (t, J=7.5 Hz, 2H), 6.12 (dt, J=16.0,
7.0 Hz, 1H), 6.59 (d, J=16.0 Hz, 1H), 7.09–7.15 (m, 4H), 7.17 (d, J=
7.5 Hz, 1H), 7.38 (d, J=7.5 Hz, 1H), 7.59 (dd, J=7.5, 7.5 Hz, 1H),
8.55 ppm (d, J=5.0 Hz, 1H); 13C NMR (CDCl3): d=19.91, 33.49, 38.41,
121.25, 123.11, 125.71, 126.15, 127.07, 128.77, 130.28, 131.14, 135.17,
136.41, 137.03, 149.53, 161.53 ppm; HRMS (DI-EI+) (m/z) observed:
223.1363 (D=+1.1 ppm); calcd for C16H17N [M+]: 223.1361.
[7] Recent examples: a) H. Someya, H. Ohmiya, H. Yorimitsu, K.
1-(4-Methoxyphenyl)-4-(2-pyridyl)-1-butene (3p): m.p.: 56–588C. IR
(nujol): n˜ =2855, 2677, 2361, 1458, 1373, 1042 cmÀ1 1H NMR (CDCl3):
;
d=2.63 (dt, J=7.0, 7.5 Hz, 2H), 2.95 (t, J=7.5 Hz, 2H), 3.79 (s, 3H),
672
ꢀ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Asian J. 2011, 6, 669 – 673